ROVI signs a co-operation agreement for a clinical trial to study the efficacy and safety of bemiparin in patients hospitalised with pneumonia caused by COVID-19

Read time: 0 mins
ROVI signs a co-operation agreement for a clinical trial to study the efficacy and safety of bemiparin in patients hospitalised with pneumonia caused by COVID-19
https://rovi.es/sites/default/files/Press%20release_Ensayo%20HM.pdf
Year: 
2020